Initiativesfor researchers and collaboration

Accelerate Brain Cancer Cure (ABC2) invests in each stage of the therapeutic development pipeline. Our Pre-Clincial Screening Program breaks down barriers to entry, our Research Grants focus on novel therapies, and our collaborations with industry allows us to bring the most promising treatments to patients quickly.

We believe innovation and solid research should not linger in research labs.  Our research grant process is designed to move the best ideas into the clinic as soon as possible.  When we review research ideas, we look for proposals which identify a clear problem and layout a clear roadmap to  find a solution.

Each year, Accelerate Brain Cancer Cure hosts a scientific meeting to give researchers, investors, policy leaders, and industry leaders the chance to discuss progress in brain cancer research. The meeting serves as a catalyst for innovation and allows scientists to form collaborations with biotechnology and pharmaceutical companies that can drive discoveries from lab to the clinic.